- Home
- BGLC vs TXMD Comparison
BGLC vs TXMD Comparison
Compare BGLC & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- TXMD
- Stock Information
- Founded
- BGLC 2017
- TXMD 2008
- Country
- BGLC Malaysia
- TXMD United States
- Employees
- BGLC N/A
- TXMD N/A
- Industry
- BGLC Medical Specialities
- TXMD Biotechnology: Pharmaceutical Preparations
- Sector
- BGLC Health Care
- TXMD Health Care
- Exchange
- BGLC Nasdaq
- TXMD Nasdaq
- Market Cap
- BGLC 10.4M
- TXMD 12.3M
- IPO Year
- BGLC N/A
- TXMD N/A
- Fundamental
- Price
- BGLC $5.53
- TXMD N/A
- Analyst Decision
- BGLC
- TXMD
- Analyst Count
- BGLC 0
- TXMD 0
- Target Price
- BGLC N/A
- TXMD N/A
- AVG Volume (30 Days)
- BGLC 178.0K
- TXMD 16.0K
- Earning Date
- BGLC 11-14-2025
- TXMD 11-11-2025
- Dividend Yield
- BGLC N/A
- TXMD N/A
- EPS Growth
- BGLC N/A
- TXMD N/A
- EPS
- BGLC N/A
- TXMD N/A
- Revenue
- BGLC $9,551,559.00
- TXMD $2,559,000.00
- Revenue This Year
- BGLC N/A
- TXMD $427.09
- Revenue Next Year
- BGLC N/A
- TXMD N/A
- P/E Ratio
- BGLC N/A
- TXMD N/A
- Revenue Growth
- BGLC 4.01
- TXMD 156.93
- 52 Week Low
- BGLC $2.01
- TXMD $0.70
- 52 Week High
- BGLC $15.60
- TXMD $2.44
- Technical
- Relative Strength Index (RSI)
- BGLC 47.38
- TXMD 44.55
- Support Level
- BGLC $5.19
- TXMD $0.99
- Resistance Level
- BGLC $5.47
- TXMD $1.11
- Average True Range (ATR)
- BGLC 0.33
- TXMD 0.03
- MACD
- BGLC -0.04
- TXMD 0.00
- Stochastic Oscillator
- BGLC 11.17
- TXMD 57.85
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.